CN114403158A - B-lysine-resistant bacillus bacteriocin analogue and application thereof in inhibition of pseudomonas syringae tomato pathogenic varieties - Google Patents

B-lysine-resistant bacillus bacteriocin analogue and application thereof in inhibition of pseudomonas syringae tomato pathogenic varieties Download PDF

Info

Publication number
CN114403158A
CN114403158A CN202111524823.0A CN202111524823A CN114403158A CN 114403158 A CN114403158 A CN 114403158A CN 202111524823 A CN202111524823 A CN 202111524823A CN 114403158 A CN114403158 A CN 114403158A
Authority
CN
China
Prior art keywords
bacteriocin
lysine
analogue
resistant
bacillus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN202111524823.0A
Other languages
Chinese (zh)
Other versions
CN114403158B (en
Inventor
马香
刘柱
唐燕琼
陈银华
胡新文
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hainan University
Original Assignee
Hainan University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hainan University filed Critical Hainan University
Priority to CN202111524823.0A priority Critical patent/CN114403158B/en
Publication of CN114403158A publication Critical patent/CN114403158A/en
Application granted granted Critical
Publication of CN114403158B publication Critical patent/CN114403158B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N63/00Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
    • A01N63/50Isolated enzymes; Isolated proteins
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/32Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Bacillus (G)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70Vectors or expression systems specially adapted for E. coli
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Plant Pathology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Agronomy & Crop Science (AREA)
  • Pest Control & Pesticides (AREA)
  • Virology (AREA)
  • Dentistry (AREA)
  • Environmental Sciences (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

The application discloses an application of a B-lysine-resistant bacillus bacteriocin analogue in preventing and treating tomato bacterial spot disease, and discloses an application of the B-lysine-resistant bacillus bacteriocin analogue in inhibiting Pseudomonas syringae tomato pathogenic varieties causing the tomato bacterial spot disease. The application also discloses a preparation method of the boron-resistant lysine bacillus bacteriocin analogue, which is characterized in that escherichia coli is used as a chassis host cell, and the boron-resistant lysine bacillus bacteriocin analogue is obtained by heterologously expressing the bacteriocin analogue gene cluster. The B-lysine-resistant bacillus bacteriocin analogue has the advantages of simple preparation method, high yield and obvious inhibition effect on Pseudomonas syringae tomato pathogenic varieties causing tomato bacterial spot diseases; and in the application of preventing and treating the tomato bacterial spot disease, the tomato bacterial spot disease is pollution-free, does not generate drug resistance on tomatoes, and can completely replace chemical prevention and treatment of the tomato bacterial spot disease.

Description

B-lysine-resistant bacillus bacteriocin analogue and application thereof in inhibition of pseudomonas syringae tomato pathogenic varieties
Technical Field
The invention relates to the technical field of microbial synthesis, in particular to a boron-resistant lysine-resistant bacillus bacteriocin analogue and application thereof in inhibiting pseudomonas syringae tomato pathogenic varieties.
Background
With the increasing of drug-resistant strains, a green and safe antibiotic substitute is urgently needed to be found at present, and microorganisms can generate various natural secondary metabolites with biological activity, so that the microbial preparation has a wide application prospect in the fields of medical treatment, agriculture, food and the like, and is expected to be one of main sources for generating new drugs. However, the problems that the biosynthesis gene cluster of certain secondary metabolites is in a silent state, the products are not easy to prepare, the yield is low and the like exist at present.
The transportation of synthetic organisms will help to solve the above problems. Synthetic biology is based on the study of system biology, introducing engineering principles and methods to construct artificial biological devices and systems with predictable behavior de novo, including computational models and modular DNA, to establish metabolic pathways and to construct biological circuits to control cellular behavior through standard design and interconnections between modular components. Therefore, the design and development of the microbial underpan cells based on the system biology and the synthetic biology can realize the construction and the modification of an excellent cell factory. At present, scientists have developed a heterologous expression synthetic biology platform, and escherichia coli is considered to be a high-efficiency heterologous host due to a complete genetic tool kit, and the purposes of discovering new compounds, clarifying a product synthesis path and optimizing product yield are achieved by combining heterologous expression path reconstruction and genetic engineering.
Pseudomonas syringae tomato pathogenic strain DC3000 (Pst DC3000) is a plant pathogenic bacterium of Pseudomonas syringae, and can cause diseases of plants such as tomato, pepper, Arabidopsis thaliana and the like. Bacterial leaf spot disease in tomato caused by PstDC3000 can infect the leaves, petioles, stems, flowers and fruits of tomato, causing severe loss of tomato yield. At present, the prevention and treatment method for the diseases mainly takes chemical prevention and treatment as a main part, has quick response, low cost and easy operation, but seriously threatens the ecological environment and human health by using a large amount of chemical agents for a long time. Therefore, the search for high-efficiency, low-toxicity, pollution-free and drug-resistance-free biological control measures has become a primary task.
Bacteriocins are a class of proteins or polypeptides with bacteriostatic activity produced by bacteria during the metabolic process by the ribosome synthesis mechanism. Bacteriocin has the advantages of small molecular weight, easy degradation by protease without residue, no toxic or side effect on human body and the like, and can be used for food preservation, human disease control, biological control and the like at present. The synthesis of bacteriocins generally requires multiple module interactions.
The invention mainly analyzes the genome, excavates the bacteriocin gene cluster, uses colon bacillus as a chassis host cell, expresses the bacteriocin gene cluster heterologously, and finally produces the bacteriocin antibacterial active substance with biological activity by using a method of redesigning a system aiming at a specific target by using synthetic biology.
Disclosure of Invention
Therefore, the invention aims to provide a boron-resistant lysine-resistant bacillus bacteriocin analogue and application thereof in inhibiting pseudomonas syringae tomato pathogenic varieties, and the technical scheme of the invention is realized by the following steps:
an application of a B-lysine-resistant bacillus bacteriocin analogue in preventing and treating tomato bacterial spot disease. The boron-resistant lysine bacillus (Lysinibacillus boronitolorans) is preserved in the China Center for Type Culture Collection (CCTCC) in 2019, 10 and 8 months, is called CCTCC for short, addresses China-Wuhan university, and has the preservation number of CCTCC NO. M2019773.
The further technical proposal is that the boron-resistant lysine bacillus bacteriocin analogue is applied to inhibiting pseudomonas syringae tomato pathogenic varieties causing tomato bacterial spot disease.
Still further, the technical solution is the use of said lysine-resistant bacillus borreligious bacteriocin analogues for inhibiting pseudomonas syringae tomato pathogenic varieties causing bacterial leaf spot disease in tomato.
According to a further technical scheme, the B.borotolerant bacteriocin analogue is applied to inhibiting the growth of the tomato pathogenic variety of Pseudomonas syringae causing bacterial spot disease of tomatoes.
The further technical proposal is that the Pseudomonas syringae tomato pathogenic variety is Pseudomonas syringae tomato pathogenic variety DC3000Pseudomonas syringae pathovar tomato, Pst DC 3000.
The bacteriocin analogue gene cluster is a DNA fragment which is 8932bp in length and is obtained by carrying out PCR amplification by using a boron-resistant lysine bacillus whole genome as a template and Bac (10) -F and Bac (10) -R as primers.
Preferably, the sequences of the Bac (10) -F primers are as follows:
TAAGGATGATTTCTGGAATTCGGCTAAGTTTTTATATGAGTAATGTCAC, as shown in SEQ ID NO. 1.
The sequences of Bac (10) -R as primers are as follows:
GTTCCACAGGGTAGCGGATCCGCCTTCTGTTACCACTTCATCAAG, as shown in SEQ ID NO. 2.
Preferably, the 8932bp DNA fragment has a sequence shown in SEQ ID NO. 3.
According to the preparation method of the boron-resistant lysine bacillus bacteriocin analogue, escherichia coli is used as a chassis host cell, and the boron-resistant lysine bacillus bacteriocin analogue is obtained by heterologously expressing the bacteriocin analogue gene cluster.
The further technical scheme is that the method comprises the following steps:
(1) extracting the genomic DNA of the B-lysine resistant bacillus and carrying out PCR amplification on a bacteriocin analogue gene cluster to obtain a DNA fragment;
(2) extracting plasmids, performing double digestion and recovering gel to obtain a vector;
(3) the DNA fragment is connected with a vector in a seamless cloning manner to obtain a cloned product;
(4) mixing the cloned product with escherichia coli competent cells, and then carrying out electric shock transformation to obtain thalli containing bacteriocin analogue gene cluster recombinant plasmids;
(5) the thalli is cultured and fermented to obtain fermentation liquor, the fermentation liquor is purified,
obtaining a purified product containing the B lysine-resistant Bacillus bacteriocin analog.
The further technical scheme is that the plasmid is p15A or pET.
The further technical scheme is that the host cell comprises E.coli BL 21.
The fermentation liquid refers to a liquid containing bacteriocin analogs generated by fermenting thalli, for example, the fermentation liquid of E.coli BL21 containing recombinant plasmids is 250mL of bacterial liquid (original OD0.02OD)600The resulting fermentation product was incubated at 37 ℃ for about 28h at 150r/min per 1000 mL/volume of medium. After fermentation, centrifuging at 9000r/min for 30min to remove precipitate, collecting fermentation supernatant, and filtering with 0.22 μm filter membrane to obtain sterile fermentation filtrate.
The ammonium sulfate precipitation method as referred to herein refers to a technique for precipitating and separating proteins using ammonium sulfate solutions of different concentrations. Ammonium sulfate precipitation can be used to concentrate and partially purify proteins from bulk crude preparations. High concentrations of salt ions compete with proteins for water molecules in protein solutions, thereby disrupting hydrated films on the protein surface, reducing its solubility, and allowing it to precipitate from solution. The solubility of each protein is different and thus different proteins can be precipitated using different concentrations of salt solution. This method is called salting out. Salt concentration is usually expressed in terms of saturation. Ammonium sulfate is most widely used because of its high solubility, low temperature coefficient and low tendency to denature proteins.
Compared with the prior art, the invention has the beneficial effects that:
(1) the B-lysine-resistant bacillus bacteriocin analogue has the advantages of simple preparation method, high yield and obvious inhibition effect on Pseudomonas syringae tomato pathogenic varieties causing tomato bacterial spot diseases; and in the application of preventing and treating the tomato bacterial spot disease, the tomato bacterial spot disease is pollution-free, does not generate drug resistance on tomatoes, and can completely replace chemical prevention and treatment of the tomato bacterial spot disease.
(2) The boron-resistant lysine bacillus bacteriocin analogs described herein are a class of proteins or polypeptides with bacteriostatic activity produced by bacteria through the ribosome synthesis mechanism during the metabolic process. The bacteriocin has the advantages of small molecular weight, easy degradation by protease without residue, no toxic or side effect on human body and the like, and can be used for biological control, food preservation, human disease control and the like.
(3) The method uses seamless cloning to construct the vector, particularly preferentially selects a target fragment when the target fragment is large, and has high success rate and simple and convenient operation.
Drawings
FIG. 1 construction of recombinant plasmid vector. FIG. 1A is a PCR amplification gel electrophoresis of the bacteriocin analog biosynthesis gene cluster; FIG. 1B is the PCR gel electrophoresis of the gene cluster heterologous expression recombinant plasmid colony.
FIG. 2 is a graph showing the inhibition of Pseudomonas syringae tomato pathogenic mutant DC3000 by bacteriocin analogs concentrated by ammonium sulfate precipitation method using a filter paper method. Wherein, FIG. 2A is a control group, which is Pseudomonas syringae tomato var infestans DC3000 treated with fermentation broth of E.coli BL 2128 h containing empty plasmid; FIG. 2B is an experimental group of Pseudomonas syringae tomato pathogenic variety DC3000 treated with E.Coli BL 2128 h fermentation broth of recombinant plasmid containing gene cluster.
(1) Detailed description of the preferred embodiments
For clear and complete description of the technical solutions in the present invention, the inventor has described the embodiments with reference to the drawings, but the following embodiments describe only some embodiments of the present invention, not all embodiments. All other embodiments, which can be derived by a person skilled in the art from the embodiments given herein without making any creative effort, shall fall within the protection scope of the present invention.
Example 1 predictive analysis of the bacteriocin analog Gene Cluster
1. Uploading the B-lysine-resistant bacillus genome file to an anti SMASH or BAGEL website, and predicting and analyzing the secondary metabolite biosynthesis gene cluster of the B-lysine-resistant bacillus genome file.
2. And (4) carrying out downstream analysis. After the gene cluster prediction is completed, downstream analysis is carried out, including structural domain analysis and annotation and core chemical structure prediction.
Cluster comparison analysis and smcAG (second approach Clusters of organisations Groups of Groups) analysis.
EXAMPLE 2 construction of Gene Cluster analog expression vector
1. And (3) extracting the genomic DNA and plasmid of the B-lysine-resistant bacillus.
5mL of overnight-cultured B.borascens-resistant bacillus liquid was taken, genomic DNA was extracted according to the instructions of the Vazyme Biotech bacterial genome extraction kit, and finally 2ul of the bacterial genome was taken. Likewise, 5mL of overnight-cultured E.coli DH 5. alpha. cells were harvested, and 2ul of plasmids were extracted according to the Vazyme Biotech plasmid Mini kit.
2. PCR amplification of B-lysine-resistant Bacillus bacteriocin analogue gene cluster.
And (3) performing PCR amplification on a target gene cluster by taking the extracted boron-resistant lysine bacillus whole genome as a template and Bac (10) -F and Bac (10) -R as primers respectively, and performing gel electrophoresis detection. The resulting DNA fragment (see FIG. 1A) with a clear band and an expected size (8932bp) indicates successful amplification of the gene cluster from the B.borotolerant genome. The PCR reaction system and amplification procedure are shown in tables 1 and 2:
TABLE 1 PCR amplification System
Figure BDA0003409809510000061
Figure BDA0003409809510000071
TABLE 2 PCR amplification procedure
Figure BDA0003409809510000072
And 3, purifying and recovering the PCR product. Product purification recovery was performed according to Vazyme Biotech product purification kit instructions, and finally 2 μ Ι _ was removed.
Double digestion and gel recovery of the p15A plasmid: the p15A plasmid was double digested with BamHI and EcoRI restriction enzymes and reacted at 37 ℃ for 6 h. After the cleavage products were separated by electrophoresis on a 1% agarose gel, the gel containing the desired DNA fragment was rapidly excised under an ultraviolet lamp and placed in a 1.5mL EP tube, and the subsequent purification steps were performed according to the Vazyme Biotech product purification kit instructions. The double enzyme system is shown in Table 3:
TABLE 3 restriction enzyme double digestion System
Figure BDA0003409809510000073
5. Seamless clonal joining. According to
Figure BDA0003409809510000074
The Ultra One Step Cloning Kit was used for the procedures. The attachment system is shown in table 4:
TABLE 4 seamless clonal ligation System
Figure BDA0003409809510000075
Figure BDA0003409809510000081
The use amount of the fragment and the vector is calculated according to the following formula, and the single fragment homologous recombination reaction is carried out. The optimum vector usage amount was [0.02 × vector base pair ] ng (0.03pmol), and the optimum insert usage amount was [0.04 × insert base pair ] ng (0.06 pmol).
② preparation of a connecting system was carried out according to Table 4.
③ reacting at 50 ℃ for 5 min; cooled to 4 ℃ or immediately placed on ice to cool.
Note: if the number of bases of the insert is much greater than the number of bases of the vector, the vector is counted as the insert.
6. The electric shock transformed BL21 competent cells. The shock conversion program was set to Bacteria. Taking out the sterilized and precooled electric rotating cup. And (3) placing the competent cells on ice for about 1min to dissolve the competent cells, adding 1-2 mu L of the ligation product or plasmid, blowing and uniformly mixing, quickly transferring the bacterial liquid into a groove of the electric rotating cup, slightly shaking for 3-5 times, quickly wiping water drops on the outer wall of the electric rotating cup, and performing electric shock transformation. After the electric transfer is finished, 1mL of LB liquid culture medium is added, the mixture is evenly blown and beaten, and the mixture is revived at 37 ℃ and 150rpm for 1 h. Centrifuging at 6000rpm for 3min to collect thallus, discarding supernatant, adding 100 μ L LB liquid culture medium, suspending thallus, spreading on spectinomycin resistant plate, and culturing at 37 deg.C for 12-16 h.
7. Screening and identifying the recombinant plasmid. A single colony on the resistant plate was picked up and placed in a 1.5mL EP tube containing 40ul of sterile water, and heated in a 100 ℃ metal bath for 10min to completely lyse the thallus. Centrifuging at 12000rpm for 1min, taking 1 μ L of supernatant as a template of colony PCR, performing PCR amplification by using F3 and R3 primers, judging the size of a PCR product through 1% agarose gel electrophoresis, and finally obtaining a verification fragment of about 581bp, wherein the verification fragment conforms to the expected fragment size, and the successful construction of the vector is indicated (see FIG. 1B). Extracting positive clones to extract plasmids, and sending to Shanghai Processingenuity Limited company for sequencing identification.
The F3 primer sequence is CCTTCTGCCACTGGTCGTTTATC, and the R3 primer sequence is GGCTTTACAGAACCGACACCAAT.
Example 3 detection of antibacterial Activity
The antibacterial activity of the bacteriocin analogue concentrated by the ammonium sulfate precipitation method on pseudomonas syringae tomato pathogenic variety DC3000 (target bacteria) is detected by using a filter paper method.
The extraction method comprises the following steps: ammonium sulfate was added to the E.coli BL21 fermentation broth containing the gene cluster recombinant plasmid or the E.coli BL21 fermentation broth of an empty plasmid to achieve ammonium sulfate saturation levels of 50%, 60%, 70% and 80%, and the mixture was precipitated overnight at 4 ℃. Centrifuging at 8000rpm for 10min, collecting precipitate, dissolving 1g precipitate with PBS (pH7.0), and diluting to 10mL volume to obtain bacteriocin analog solution (to-be-detected solution I) with different ammonium sulfate saturation and fermentation broth extract solution (to-be-detected solution II) of empty plasmid E.Coli BL 21.
A single colony of the target bacterium was picked up and cultured in 5mL of LB liquid medium at 37 ℃ for 12 hours at 150 rpm. By OD600Initial inoculum size of 0.02 was transferred to 20mL LB liquid medium and cultured to OD6000.4-0.6. Get 108The bacterial solution was centrifuged at 6000rpm for 3min in a 1.5mL EP tube, the supernatant was discarded, 1mL of fresh LB medium was added, and the mixture was blown up and mixed.
Pipette 500. mu.L onto LB solid medium and spread well with sterile cotton swab. A 6mm sterile filter paper sheet (5 layers) was placed on the surface of the medium coated with the target bacteria.
Dripping the solution I to be detected with different ammonium sulfate saturation degrees prepared in advance onto a filter paper sheet, wherein the total amount is 80 mu L (dripping a small amount of solution for multiple times); and dropping the solution II to be detected with the corresponding ammonium sulfate saturation onto a filter paper sheet as a control, placing the filter paper I to be detected and the filter paper II to be detected with the same ammonium sulfate saturation on the same flat plate, and arranging three parallel plates for each ammonium sulfate saturation for 12 flat plates. After the culture at 30 ℃ for 12h, the growth of the target bacteria is observed, and as a result, the growth inhibition effect of the bacteriocin analogue solution with the saturation degree of ammonium sulfate of 80% on the growth of the pseudomonas syringae tomato pathogenic variety DC3000 is obvious, as shown in figure 2.
As shown in FIG. 2, the E.coli BL 2128 h fermentation broth of the recombinant plasmid containing the gene cluster treated the Pseudomonas syringae tomato pathogenic variant DC3000 showed a zone of inhibition, while the E.coli BL21 fermentation broth treated the Pseudomonas syringae tomato pathogenic variant DC3000 containing the empty plasmid did not show a zone of inhibition, which indicates that the bacteriocin analog of B-lysine-resistant Bacillus described in this application can be used to inhibit the biocontrol activity of the Pseudomonas syringae tomato pathogenic variant DC3000 by heterologous expression of the bacteriocin analog.
The above description is only for the purpose of illustrating the preferred embodiments of the present invention and is not to be construed as limiting the invention, and any modifications, equivalents, improvements and the like that fall within the spirit and principle of the present invention are intended to be included therein.
Sequence listing
<110> university of Hainan
<120> B-lysine-resistant bacillus bacteriocin analogue and application thereof in inhibition of pseudomonas syringae tomato pathogenic varieties
<160> 3
<170> SIPOSequenceListing 1.0
<210> 1
<211> 49
<212> DNA/RNA
<213> Artificial Sequence
<400> 1
taaggatgat ttctggaatt cggctaagtt tttatatgag taatgtcac 49
<210> 2
<211> 45
<212> DNA/RNA
<213> Artificial Sequence
<400> 2
gttccacagg gtagcggatc cgccttctgt taccacttca tcaag 45
<210> 3
<211> 8932
<212> DNA/RNA
<213> Lysinibacillus boronitolerans
<400> 3
ggctaagttt ttatatgagt aatgtcacac tttatgcaga tttaataaaa aaagatgctt 60
gaacaaggtc tattgaccca tcaaacatct actgtttttt atataaaatc aatatatttt 120
tatacatttc tattgaaagc aaaattgtta ttacattgaa tggaatacac agaccaattg 180
tttcaatttt agcttcatgt cacttaacaa gcttcaaaat ggttttaaaa tgttcatgat 240
ctgcacgttg taatagctca tacaagatca tttcggtgct agttggataa ataccaaggg 300
cattcatctt cgtaagccca atttctttat ttgcctttgt tcgagaagat acggcgtcta 360
caacaacctc tacttcaaat ccttgttctt tcagttgtct agccgtttga tacacacaaa 420
tatgtgtttc gatacctgtg acaatgaatt gagaacgtcc attttccttt atcgcttcta 480
caaatgcctc ttcttggcac gcactaaagg ccattttggc aataggttgc ccttgtaaat 540
gctgtgcaat atcaagtgcc gttccgccta atcgacttgg attttgttct agccacaaaa 600
taggtacttc gagtgccttc atcgcttgta ctagctttgc tacattttca attaccgttt 660
cactgtcatc aacaattgtt gctaactttc cttgcacatc tacaactact aaacaagctt 720
tctctacagt aaacatcctg aacacctctt tttcttttct taataatatt atacaaaaac 780
ttgcttacct ctcgtaaagt aataaggaac tttctctaac aatcgattgg atagttttgc 840
tttagcctgt ccatttcacg cttctaccaa ggaaatattt gcaagcaaaa acacgaacaa 900
tatcattttt attgcaataa aaaatattta atatacggaa aatataactt aatttcaaaa 960
atacctttct atttgttcgt ttttaatgaa aaatacctgc ttaaatgtgt acattttgtt 1020
gcgagcctgt cgccattctg ctcaaatatt aagaatttta ttttttctct tgaaaattag 1080
gttataatcc agtaaagttc tgttattaac caaacaagga gtgtaccact ttgacacaac 1140
gtgcatacaa tttcaacgca ggtccatctg ctctaccaca agaagtatta gaaaatgctc 1200
aacagcaatt agtaaacttc cgtgattcag gtatgtccat tatggaaatg agtcaccgta 1260
gtgccatttt cgatgaagta cataatgaag ctattacttt attaaaaaaa ctttatgcta 1320
ttccagaaaa ctatgaggta ctattcttac agggtggagc aagccttcag tttacaatgg 1380
tgcctatgaa cttcttaaca actgagcaaa aagctagcta tgtattatca ggctcatggt 1440
ctgagaaagc ttttaaggaa gctaaattat ttgggacacc tgttgaagct gcaagcacaa 1500
aagaaaacca ataccgcaat attcctgctt tagaagatat tcaattcaat gaagatgatg 1560
catatgttca catcacatcc aataatacga tatatggtac acaatggaaa aatttcccta 1620
gcacaggaaa tgttccatta gtggcggata tgtcaagtga catcctatca aaaccagtgg 1680
atattgaaaa attcggtatc atctatgcag gagctcaaaa aaaccttggc ccttcaggtg 1740
taacggtcgt gattattcgc aaagatttac ttgaaaaagc aaataaaaat ataccaacga 1800
tgttaaagta tacaacacat gctgatagta attctcttta taatacacct ccgacattcg 1860
gaatctatat gctcggcgag gtattaaaat gggtagaagc taaaggcggc gtagcagcaa 1920
ttgaaaaaca taatgaatta aaggcaaaag tgatttatga tgccattgac aatagtaatg 1980
gtttctacaa aggccatgcc acacctgaaa gccgttcttt aatgaacatt acattccgtg 2040
ttgcagatga ggagctagaa aaacaattcc ttgcagaggc aaaggcagca ggttttatcg 2100
ggctaaatgg acatcgttct gttggcggct gtcgtgcttc cacttataat gcagtgccac 2160
ttgaggcttg cgaagcttta cgagatttca tggtaaattt ccaacaaaaa catcaataaa 2220
cttctattta aaagatgagt ctttccattt cggtaaagac tcatcttttt ttcgcgcttt 2280
tcgaaggaaa tatgaaatct atccccatac aattagcttg attagatgtt tatagcaata 2340
tttcagctta gggctttaca cattgcaaaa gtttttgaga aaaatataga tttttaagct 2400
gcctatcgga catatcgcca gtctctagct atgcaccaaa catagattat tactgtaagg 2460
gttaccttta cgaaactaga ggaagggagg tctagacaat ggaagataaa agatatatgt 2520
cacatatgaa ctggcaaggc tgtaaatgtc ctaaaaaaga ggaaaaatgc tgtcaacgta 2580
aagttgaaaa atgtcattgc caaaaagagg aaaaatgcca ttgtaaaaaa gaagaaaaat 2640
gtacaccaag aatgagcagc cactgtagag gctgtatttg tcaccaatta agaaaattag 2700
agctagctac tacactagat atcttcttat ctggaggtat tagcttctta ggtgtgactt 2760
tcatttccct cgatcaaaga aattgctgtg catacttcct tgagccaggt gcagctgctg 2820
cttctccttt aatcgtagat tgcaataaaa ttgttgcgat tcgtcgagta gtgtagctta 2880
attaatatag agggtagcct tatacaggca ccctcttctt acatagaaaa aacgctgtca 2940
tatttaaagt gacagcgttt catgcttaca atccgggcat ttaccatata tttcaaactt 3000
atgattttca atttcataat caggtaattt ttcacctaac atttccattg gacaaagatt 3060
aagctctttg acgttgccac aatccataca gataaaatga tggtgatgat gcgcagattc 3120
acagtgcata cggaaattac gttcccctga tagctctgtt tcttctaata tcccaagttt 3180
cacaaaagta gcaaggttac gataaatggt atcaaaactc attcccggaa aatccttttt 3240
tagaacatcc aataaatcac gggctgttag atatttatct gttgctgcaa acatatctaa 3300
tattaactcc cgtttatctg tttttttata gccattttcc tttaatattt cccacgctct 3360
tgaaatattc attgcgctac ctccccctgc tttgcagcca ttttaaatgc tactttcttt 3420
cctaggatta caagtaacaa aatcaaaata gaagtgacaa caattgtgcc tcccggtgct 3480
aaatccatat aaaatgcact aattagacca attagtacag cagtttctcc aaaaacaata 3540
gcataaatga tggtttgctt aaagcccttt gccaagcgca ttgctgctgc gacaggtaat 3600
gtcatcagag atgatacaag taaaatacct actatgcgca tacttgccgc aatgacaagc 3660
gcagtcacaa tcataaataa aagatgaacc caacgagctg gaagtccact agcttttgca 3720
tattcctcat caaaagacaa aacaaataat tctttaaaaa ataaaaataa aaaaataatt 3780
acaatggcag caattccgat caccacccat aaatcttgac gagatacagc agaaaccgag 3840
ccaaacaaat aactcattaa atctgtgcta aagccactgg caagtgagat aaagatggcg 3900
ctaatcccaa taccacctga cataatgatt ggaatggcaa gctcctcata gtgcttatat 3960
aaacgtctta aacgctcaat caaaatagag ccactaacag aggctagtat acctaaataa 4020
ataggattga gcattgctaa ggctgataca gattgactga tgtataaact cccagcgatt 4080
ccagcgagtg ttacatgtga caaagcatcg gcaatcaagg acagcctacg tacaacaata 4140
aacaccccca gcagtggtgc aagtatgcca attaataatc cagagaaaaa ggcattttgt 4200
aaaaattcat aatgtaaaat tgcttcaatc atgtgcctac tccttctaat gaatctttct 4260
cacggaatgg ccataccaag catctagcgc gtcctgagaa atattatcaa attcattttt 4320
atagccgtgg aagtgaatgg tttgatttaa acatgccaca tgactaatac gatttgatac 4380
cgtatcgaca tcgtgtgtga caagaatcat cgtaattcct tgttcccgat ttaatttcgc 4440
cagcatatca taaaatgact gcacgttctc gtgatcaatg ccgacagttg gctcatctaa 4500
aatgagcagt ttaggatcac tgactaaagc tcttgcaata aaaacacgtt gttgttgtcc 4560
accagataat tctccaatat tgcgattcat ataagcatcc atgccaactg cctttaaagc 4620
ttcttgaact ttgtctttgg cgtctcggcc aggtctttta aaaagcccta atttttttgt 4680
taatccactt ttcacgacct cttgcacggt tgctgggaac ccagaattaa aggcattgga 4740
tttttgtgag acatagccaa tccattcacg gtgcttaaag ttcgcgcttg tttcaccaaa 4800
tagctttatt tcaccagata aaggtttcaa caaacctaaa ataattttta ataatgttga 4860
ttttcccgaa ccatttggac cgagaagtgc taaaaaatct ccctcttcta cacgaaaaga 4920
aatgtttttt aaaacttgcg tatagtcata ttgaaatgac acattttcaa tgtcaataag 4980
tgttgttttc atgcatgatc gcttctttct aattcaaaat cattacgatt tacaaattgt 5040
aagtataaag gaaagtgcag tttttgtaaa gaaaagaaga tggatgcttt ttcgaatagg 5100
ctgatggcaa gtgtgtaaaa cgtgaaaata aaatggggta aaggaggatt gactttgagt 5160
attcaatttt tacagcaatt agcacaaagc acggataagg aaattgtcgc gattgctcgt 5220
gaagaaggtt ttagcattac gacttctgaa gtaaaaaaac ttcgacctta tttggagcaa 5280
ttctcatttt cttggctatt tttaggtatt cctaaagata ttcttgttga agtggaagct 5340
gttttaggga gaaagcgctc tcgccaactg attgccttgt ttacaaaata aaaaaagccc 5400
gaaatcagaa ccagcctgat ttcgggttag ttatattagc cctttaaagc ttcaatatgc 5460
tcaggcttaa atgtaccgtt tcgtaacata tcgatttcca ctttatacgg agctacctta 5520
gatttagcgt cactagtgag agggacaaac ggtgtctcta aaattttagg aacatccatt 5580
aattgtggat ggtgtactac atagttgagg gcatcaaagc caatatgacc aaagccaata 5640
ttttcgtggc gatccttacc tgcaccgcgc acatttttgg agtcattgat atgcaatact 5700
ttaatgcgtt ccacacctat tattttatca aattcgttta ataccccatc aaaatcttcc 5760
acaatattat agccagcatc atgtgtatga caagtatcaa agcatacaga aagtcgctcg 5820
ttatttgtta caccatcaat aattttagca agctcttcaa aggaacgtcc acattctgtc 5880
cccttccctg ccatggtttc taatgcaatt tgaacgggat agtcttgaga taaaacctca 5940
tttaaacctt caataatttt agcaatacca gcatcagcac cagctcctac atgggcacca 6000
ggatgtaaca caatttgcgt tgcctccagt gctgcagtac gttcaatttc cgattgtagg 6060
aaatctacac cgagacggaa tgtttctggt ttttctgtat tgccaatatt aataatgtaa 6120
ggtgcatgta caacaatatt ggtcatacca tgctctttca tatgcaggag tccattcatg 6180
atgtttaagt cagcaatggc tttgcgacgc gtattttgcg gtgctccagt ataaatcata 6240
aatgtattgg ctccgtatga cagtgcctct ttactagagc caagtagcat ttctttcccg 6300
ctcatcgaaa catgtgagcc aagtaacatg taaaagcccc cttatttttt acctcgtgct 6360
tttaagcgac gttcacgttt tttaattttt tccatttccc acttcatatt acgtttgtat 6420
ccaggtttta cctttttagg cttacgtacc aacgcttttg ctttcacatc aatttcattt 6480
tcttgcttca cacgattttt acgtgcatga cgctctttta actctgacca ttcgccatct 6540
tttacatctt tttgcacaaa aggaatgccc attttttcta cgcgaactac tgcatcctcg 6600
tctgatggct caaataatgt aatggctgtc cctttattgc ctgcacgcgc tgttcgacca 6660
acacggtgaa taaagaattc taagtcctct ggaatctcgt agttaataac atgagaaatg 6720
ccttggatat caataccacg agcagctaag tcagttgcta caatgtattg gtagtcaagc 6780
tcacggattt gcttcatcat ttttttacga tcacgtggac ttaagtcacc atgaatttga 6840
ccacaacgga taccatgctc atttaagtag ccagcaacgt gttctgctgt tttacgtgtg 6900
ttggtaaaga taacagctaa aaagggatta atgccctcaa tgacttctaa taaacgttta 6960
ttacgcgatt ttgagcgcac tggtacaagc acaaaatcga tgccttctgc cactggtcgt 7020
ttatcattca tatggacgtg cactggcgct tccatatatt tctttaaaaa tggctgaagt 7080
ttttctggaa ttgttgcaga aaaaacatac atttcaagct tttctggcat ctgtgaagca 7140
aatccatcaa tctcttcaat gaagcccata tcaaaagcta gatccgcttc atcaacaact 7200
aagattggtg ctgtatgcac aaataacgct tgtgctgaaa caaggtcacg aatacgtcct 7260
ggtgttccaa caacaatttg tggctgtgtt tttaatttat caatggagcg ttgtttgtcc 7320
gtacccccaa taaatagttt tgcttgaatc gcagttcctt ctattaattg atttaatgca 7380
tcaaaaattt gttgtgctaa ctctcgagta ggagaagtaa taacagcctg tacttcctgt 7440
ttttctacat caatacgttg aacaatcggg attaaaaaac tatgtgtttt ccctgttcct 7500
gtatgtgcct gtccaatagc actttttcct tttaataaaa gcggaataat ttctttttga 7560
attggtgtcg gttctgtaaa gcctagattt gcaatggcgt cctgcaaaaa tggctgaaaa 7620
ttataatcag tatattttga catcattcgt tcctcctaac atctttttca ttgtaccatg 7680
attcgaactt taaggtatat ttacgttcta tttcttacta gcataaacat atttttaatg 7740
ttttattatc accgtaacaa agcccttatc aaaggtactt gaaatacgca gaatatgcaa 7800
tcaaaaaagc gctgcaacaa tgttcgaaaa cgcttgtaat atgtaatttt tatgtcaatt 7860
tatagggaac taatgattag cagatttccc acatgttatg atagagctgt aagatattat 7920
gggaggttgg tagattatga aagcagcaag atggtataaa gcaaaagaca tccgtgtaga 7980
aaacattgaa gaaccagtca tcgcacctgg aaaagtaaaa attaaagtac attggacagg 8040
gatttgtggc agtgatttac atgaatacgc agctgggcca atctttattc cagtggagca 8100
acctcactat gtaagtaaag acatcgcacc cattgtgatg ggacatgaat tttcaggaga 8160
agtagttgaa attggcgatg gtgtaacatc tgttcaaata ggagatcctg tagtagtaga 8220
accaatcctt gcatgtggcg aatgtgctgc ttgtaaaaaa ggtaaatata atatttgtaa 8280
acatttaggt ttccacggtc tttcaggcgg tggcggagga ttctccgaat atacaatggt 8340
agatgaaaaa atggttcaca aaatgccaga agggctttct tatgagcaag gagcacttgt 8400
agaaccagcg gcagtcgctt tacatgccgt gcgtcaaagt aaattaaaag ccggtgacaa 8460
agctgccgtc tttggaacag gaccaatcgg gcttcttgtt attgaagcat tacgtgcagc 8520
aggcgcagca gaaatctatg ctgtagagct ttcagcagag cgtgccgcaa aagctttaga 8580
acttggtgca acagccgtca ttaaccctaa agaggaagat gccgttgtgc gtctgcatga 8640
attaacaaat ggtggtgtag atgttgcctt tgaagtaacg ggcgttcctg tggttttaca 8700
acaagctatt gactcaacaa cttttgaagg tgaaacaatc attgtgtcga tttgggagtc 8760
tacagctgct atccaaccga acaatattgt tctatcagag cgaacagtca aaggaattat 8820
tgcctaccgt gatattttcc cagccgtgat ggagctaatg acacaaggtt acttcccagc 8880
agacaagctt gttacaaaac gaattgctct tgatgaagtg gtaacagaag gc 8932

Claims (10)

1. An application of a B-lysine-resistant bacillus bacteriocin analogue in preventing and treating bacterial spot disease of tomato.
2. The borotolerant lysine bacillus bacteriocin analog of claim 1, wherein: the use of said lysine-resistant bacillus boronisin analogs in the inhibition of pseudomonas syringae tomato pathogenic variants causing bacterial leaf spot disease in tomato.
3. The borotolerant lysine bacillus bacteriocin analog of claim 2, wherein: the use of said lysine-resistant bacillus boronisin analogs in inhibiting the growth of pseudomonas syringae solanacearum varieties that cause bacterial leaf spot disease in tomatoes.
4. The borotolerant lysine bacillus bacteriocin analog of claim 2 or 3, wherein: the Pseudomonas syringae tomato pathogenic variety is Pseudomonas syringae tomato pathogenic variety DC3000Pseudomonas syringae pathovar.
5. A boron-tolerant lysine bacillus bacteriocin analog according to claims 1-3, characterized in that: the bacteriocin analogue gene cluster is a DNA fragment which is 8932bp in length and is obtained by carrying out PCR amplification by using a boron-resistant lysine bacillus whole genome as a template and Bac (10) -F and Bac (10) -R as primers.
6. The borotolerant lysine bacillus bacteriocin analog of claim 5, wherein: the sequence of the Bac (10) -F primer is shown as SEQ ID NO. 1; the sequence of Bac (10) -R as a primer is shown in SEQ ID NO. 2.
7. The borotolerant lysine bacillus bacteriocin analog of claim 5, wherein: the sequence of the 8932bp DNA fragment is shown in SEQ ID NO. 3.
8. The method of preparing a borotolerant lysine bacillus bacteriocin analog of claim 5, wherein: and (3) taking escherichia coli as a chassis host cell, and heterologously expressing the bacteriocin analog gene cluster to obtain the boron-resistant lysine bacillus bacteriocin analog.
9. The method of claim 8, wherein the method comprises the steps of: the method comprises the following steps:
(1) extracting the genomic DNA of the B-lysine resistant bacillus and carrying out PCR amplification on a bacteriocin analogue gene cluster to obtain a DNA fragment;
(2) extracting plasmids, performing double digestion and recovering gel to obtain a vector;
(3) the DNA fragment is connected with a vector in a seamless cloning manner to obtain a cloned product;
(4) mixing the cloned product with escherichia coli competent cells, and then carrying out electric shock transformation to obtain thalli containing bacteriocin analogue gene cluster recombinant plasmids;
(5) and (3) culturing and fermenting the thallus to obtain a fermentation liquor, and purifying the fermentation liquor to obtain a purified product containing the boron-resistant lysine bacillus bacteriocin analogue.
10. The method of claim 9 for the preparation of a borotolerant lysine bacillus bacteriocin analog, wherein: the plasmid is p15A or pET, and the colibacillus comprises E.coli BL21.
CN202111524823.0A 2021-12-14 2021-12-14 B-lysine-resistant bacillus bacteriocin analogue and application thereof in inhibition of pseudomonas syringae tomato pathogenic varieties Active CN114403158B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202111524823.0A CN114403158B (en) 2021-12-14 2021-12-14 B-lysine-resistant bacillus bacteriocin analogue and application thereof in inhibition of pseudomonas syringae tomato pathogenic varieties

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202111524823.0A CN114403158B (en) 2021-12-14 2021-12-14 B-lysine-resistant bacillus bacteriocin analogue and application thereof in inhibition of pseudomonas syringae tomato pathogenic varieties

Publications (2)

Publication Number Publication Date
CN114403158A true CN114403158A (en) 2022-04-29
CN114403158B CN114403158B (en) 2022-07-05

Family

ID=81268016

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202111524823.0A Active CN114403158B (en) 2021-12-14 2021-12-14 B-lysine-resistant bacillus bacteriocin analogue and application thereof in inhibition of pseudomonas syringae tomato pathogenic varieties

Country Status (1)

Country Link
CN (1) CN114403158B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114209811A (en) * 2021-12-15 2022-03-22 海南大学 Preparation method of boron-resistant lysine-resistant bacillus bacteriocin analogue and application of boron-resistant lysine-resistant bacillus bacteriocin analogue in inhibition of bacillus pumilus

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111100806A (en) * 2019-10-11 2020-05-05 海南大学 Areca-nut root rot bactericide prepared by taking boron-resistant lysine bacillus as underpan cells
CN111187726A (en) * 2019-10-11 2020-05-22 海南大学 Rice blast bactericide prepared by using lysine-resistant bacillus borreliensis as chassis cells
CN113416670A (en) * 2021-06-10 2021-09-21 江苏省农业科学院 Boron-resistant lysine bacillus with bacteriostatic ability and application thereof
CN113652367A (en) * 2021-07-29 2021-11-16 海南大学 Dragon fruit canker bactericide and application thereof

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111100806A (en) * 2019-10-11 2020-05-05 海南大学 Areca-nut root rot bactericide prepared by taking boron-resistant lysine bacillus as underpan cells
CN111187726A (en) * 2019-10-11 2020-05-22 海南大学 Rice blast bactericide prepared by using lysine-resistant bacillus borreliensis as chassis cells
CN113416670A (en) * 2021-06-10 2021-09-21 江苏省农业科学院 Boron-resistant lysine bacillus with bacteriostatic ability and application thereof
CN113652367A (en) * 2021-07-29 2021-11-16 海南大学 Dragon fruit canker bactericide and application thereof

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
VARISH AHMAD,ET AL.: "Efficacy of a novel bacteriocin isolated from Lysinibacillus sp. against Bacillus pumilus", 《LWT - FOOD SCIENCE AND TECHNOLOGY》 *
李大勇: "水稻抗病相关RNA解旋酶基因OsBIRH1的功能分析及YTH蛋白基因家族的初步研究", 《中国优秀博硕士学位论文全文数据库(博士) 农业科技辑》 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114209811A (en) * 2021-12-15 2022-03-22 海南大学 Preparation method of boron-resistant lysine-resistant bacillus bacteriocin analogue and application of boron-resistant lysine-resistant bacillus bacteriocin analogue in inhibition of bacillus pumilus
CN114209811B (en) * 2021-12-15 2024-03-29 海南大学 Preparation method of boron-resistant lysine bacillus bacteriocin analogue and application of boron-resistant lysine bacillus bacteriocin analogue in inhibition of bacillus pumilus

Also Published As

Publication number Publication date
CN114403158B (en) 2022-07-05

Similar Documents

Publication Publication Date Title
AU2024200388A1 (en) Nitrogen fixation using refactored nif clusters
US7341868B2 (en) Plasmid encoding IAA and a method thereof
Huddedar et al. Isolation, characterization, and plasmid pUPI126-mediated indole-3-acetic acid production in Acinetobacter strains from rhizosphere of wheat
CN1031252A (en) Halogenated aromatic base nitrile degrading genes, its cell that uses and contain this gene
Nambiar et al. Limiting an insect infestation of nitrogen-fixing root nodules of the pigeon pea (Cajanus cajan) by engineering the expression of an entomocidal gene in its root nodules
CN105420154A (en) Double knockout recombinant rhodococcus as well as construction method and application thereof
CN109971773A (en) The gene dsmI of the gentianic acid dioxygenase DsmI encoding degradable 3- chlorine gentianic acid a kind of and its application
CN111041036B (en) Coding insecticidal protein insect-resistant fusion gene mCryAb-VIP3A, expression vector and application thereof
CN114403158B (en) B-lysine-resistant bacillus bacteriocin analogue and application thereof in inhibition of pseudomonas syringae tomato pathogenic varieties
CN113461789B (en) LysR family transcription regulation protein derived from Burkholderia, gene and application
CN111117942B (en) Genetic engineering bacterium for producing lincomycin and construction method and application thereof
CN102115720A (en) Pediococcus acidilactici strain and method for producing pediocin by using same
JPS62503074A (en) Methods for stabilizing unstable genetic replicons
Lee et al. Effects of osmotic pressure on production of recombinant human granulocyte-macrophage colony stimulating factor in plant cell suspension culture
CN114209811B (en) Preparation method of boron-resistant lysine bacillus bacteriocin analogue and application of boron-resistant lysine bacillus bacteriocin analogue in inhibition of bacillus pumilus
JP4221476B2 (en) Plasmid cloned icosapentaenoic acid biosynthesis genes and cyanobacteria producing icosapentaenoic acid
CN114304192B (en) Preparation method of boron-resistant lysine-resistant bacillus bacteriocin analogue and application of boron-resistant lysine-resistant bacillus bacteriocin analogue in prevention and treatment of cassava bacterial wilt
CN109266676A (en) A kind of method of electroporated Siam bacillus
CN111139208B (en) High-yield engineering bacterium for producing ivermectin and preparation method and application thereof
CN111139207B (en) Brevibacillus brevis gene recombinant strain and preparation method and application thereof
US20120015404A1 (en) Gene cluster for thuringiensin synthesis
CN109897863A (en) A kind of method for transformation of Lactobacillus brevis
CN113980945B (en) Trichoderma viride histone deacetylase and encoding gene and application thereof
CN114806992B (en) RSH over-expression genetic engineering amylase streptomyces chromogenes and method for improving fermentation yield of toyocamycin
CN102766643A (en) Gene aroA for encoding 5-enolpyruvyl-shikimate-3-phosphate synthase and application thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant